158 related articles for article (PubMed ID: 36525697)
1. National assessment of lymph node status indicators & predictors in pediatric head and neck rhabdomyosarcomas in the US.
Fei-Zhang DJ; Park AC; Berry JM; Arch RS; Chelius DC; Sheyn AM; Rastatter JC
Int J Pediatr Otorhinolaryngol; 2023 Jan; 164():111419. PubMed ID: 36525697
[TBL] [Abstract][Full Text] [Related]
2. Pediatric head and neck rhabdomyosarcoma: An analysis of treatment and survival in the United States (1975-2016).
Darwish C; Shim T; Sparks AD; Chillakuru Y; Strum D; Benito DA; Monfared A
Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110403. PubMed ID: 33049553
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
4. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
Rodeberg DA; Garcia-Henriquez N; Lyden ER; Davicioni E; Parham DM; Skapek SX; Hayes-Jordan AA; Donaldson SS; Brown KL; Triche TJ; Meyer WH; Hawkins DS
J Clin Oncol; 2011 Apr; 29(10):1304-11. PubMed ID: 21357792
[TBL] [Abstract][Full Text] [Related]
5. Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.
Ben-Arush M; Minard-Colin V; Scarzello G; Fajardo RD; Terwisscha Van Scheltinga S; Bernier V; Jenney M; Gallego S; Zanetti I; Cesen M; Merks JHM; Bisogno G
Eur J Cancer; 2022 Sep; 172():119-129. PubMed ID: 35763871
[TBL] [Abstract][Full Text] [Related]
6. Quality assessment of lymph node sampling in rhabdomyosarcoma: A surveillance, epidemiology, and end results (SEER) program study.
Lobeck I; Dupree P; Karns R; Rodeberg D; von Allmen D; Dasgupta R
J Pediatr Surg; 2017 Apr; 52(4):614-617. PubMed ID: 27642084
[TBL] [Abstract][Full Text] [Related]
7. Lymph node ratio as a prognostic factor in head and neck cancer patients.
Chen CC; Lin JC; Chen KW
Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
[TBL] [Abstract][Full Text] [Related]
8. Head and neck rhabdomyosarcoma in children: a 20-year retrospective study at a tertiary referral center.
Häußler SM; Stromberger C; Olze H; Seifert G; Knopke S; Böttcher A
J Cancer Res Clin Oncol; 2018 Feb; 144(2):371-379. PubMed ID: 29143871
[TBL] [Abstract][Full Text] [Related]
9. Population-based survival of pediatric rhabdomyosarcoma of the head and neck over four decades.
Curry SD; Jiang ZY; Jain KS
Int J Pediatr Otorhinolaryngol; 2021 Mar; 142():110599. PubMed ID: 33422992
[TBL] [Abstract][Full Text] [Related]
10. Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survival.
Zhao D; Zhou F; Liu W; Huang Z; Xu X; Zheng B; Liu C; Bai C; Liu J; Sun Y; Wang W; Xiao S
BMC Cancer; 2024 Mar; 24(1):340. PubMed ID: 38486204
[TBL] [Abstract][Full Text] [Related]
11. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
12. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance features and cranial nerve involvement in pediatric head and neck rhabdomyosarcomas.
Talenti G; Picariello S; Robson C; Mertiri L; Russo C; Slater O; Bisdas S; Abate ME; Perrotta S; Hewitt R; Mankad K; D'Arco F
Neuroradiology; 2021 Nov; 63(11):1925-1934. PubMed ID: 34304299
[TBL] [Abstract][Full Text] [Related]
14. In transit metastases in children, adolescents and young adults with localized rhabdomyosarcoma of the distal extremities: Analysis of the EpSSG RMS 2005 study.
Terwisscha van Scheltinga CEJ; Wijnen MHWA; Martelli H; Guerin F; Rogers T; Craigie RJ; Burrieza GG; Dall'Igna P; De Corti F; Smeulders N; van Rijn RR; Fajardo RD; Mandeville HC; Zanetti I; Coppadoro B; Minard-Colin V; Jenney M; Bisogno G; van Noesel MM; van der Steeg AFW; Merks JHM
Eur J Surg Oncol; 2022 Jul; 48(7):1536-1542. PubMed ID: 35307252
[TBL] [Abstract][Full Text] [Related]
15. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.
Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR
Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110
[TBL] [Abstract][Full Text] [Related]
16. Rhabdomyosarcoma of the oral and maxillofacial region in Jordanians: a retrospective analysis.
Al-Khateeb T; Bataineh AB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 May; 93(5):580-5. PubMed ID: 12075208
[TBL] [Abstract][Full Text] [Related]
17. Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Gallego S; Zanetti I; Orbach D; Ranchère D; Shipley J; Zin A; Bergeron C; de Salvo GL; Chisholm J; Ferrari A; Jenney M; Mandeville HC; Rogers T; Merks JHM; Mudry P; Glosli H; Milano GM; Ferman S; Bisogno G;
Cancer; 2018 Aug; 124(15):3201-3209. PubMed ID: 29797665
[TBL] [Abstract][Full Text] [Related]
18. Primary tumor size predicts pathologic findings in the retroperitoneal lymph nodes in patients with paratesticular rhabdomyosarcoma.
Alanee S; Holland B; Dynda D; Kamel O; Ganai S
Virchows Arch; 2014 Dec; 465(6):697-701. PubMed ID: 25293343
[TBL] [Abstract][Full Text] [Related]
19. Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study.
Glosli H; Bisogno G; Kelsey A; Chisholm JC; Gaze M; Kolb F; McHugh K; Shipley J; Gallego S; Merks JHM; Smeele LE; Mandeville H; Ferrari A; Minard-Colin V; Corradini N; Jenney M; Zanetti I; De Salvo GL; Orbach D;
Eur J Cancer; 2021 Jul; 151():84-93. PubMed ID: 33971448
[TBL] [Abstract][Full Text] [Related]
20. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
Jacobs AJ; Morris CD; Levin AS
Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]